NorthWest Biotherapeutics Inc (NWBO)

[Nemesis18]

Obviously, ahead of any regulatory determination, as to the veracity of my lengthy receipted testimony, I cannot expend my carefully considered comments further.

Fortunately, the scheduled CHM meeting, created a natural pinch-point in the Process of the Regulators’ Investigations into my claims.

Which meant that now they were in receipt of detailed, pertinent patient testimony ahead of meeting, they had a statutory obligation to consider it.